Barclays (LON:BARC) analysts adjusted their outlook on GE Vernova (NYSE:GEV), increasing the price target from $420.00 to $487.00 while maintaining an Overweight rating on the company's shares. The ...

Stock analysts at William Blair dropped their Q1 2025 earnings per share estimates for GE Vernova in a research report issued to clients and investors on Thursday, January 23rd. William Blair analyst ...

GE Healthcare, the healthcare business of GE, is showcasing its advanced portfolio of patient monitors at Arab Health 2012, the region's premier health sector exhibition to be held from January 23 to ...